Navigation Links
Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Case List in New Jersey Mirena Litigation
Date:7/12/2013

ef)">Mirena class action lawsuit, all of these claims will maintain their individual identity.

The Mirena IUD was approved by the U.S. Food & Drug Administration (FDA) as a birth control method in 2000. According to a recent report from NewsChannel5 in Cleveland, Ohio, Mirena is now used by more than two million women in the U.S. However, the same report revealed that the FDA has received more than 70,000 Mirena side effects reports since the IUD was first brought to market. Since 2008, the agency logged more than 4,700 complaints of device dislocation involving Mirena, and 1,300 reports of uterine perforations.*

According to court documents, plaintiffs in Mirena lawsuits allege Bayer has a history of overstating the efficacy of Mirena and understating its risks. In 2009, FDA issued a warning letter that raised similar concerns about one of Bayer’s Mirena promotional campaigns. Among other things, the letter cited Bayer for making statements that indicated Mirena would help a woman “look and feel great,” and improve her sex life.**

Alleged victims of serious Mirena side effects may be entitled to compensation for their medical bills, lost wages, pain and suffering and other damages. To learn more about Mirena IUD lawsuits, please visit Bernstein Liebhard LLP’s website. To arrange for a free evaluation of your case, please call 800-511-5092.

*newsnet5.com/dpp/news/local_news/investigations/thousands-of-women-complain-about-dangerous-complications-from-mirena-iud-birth-control
*fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM197229.pdf

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defect
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mirena IUD Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Case Management Conference in Federal Mirena Side Effects Litigation
2. New Mirena IUD Complications Lawsuits Allegations Report: Resource4thePeople Reports Important Multidistrict Litigation Hearing Scheduled
3. Mirena IUD Birth Control Device Perforated Kentucky Woman’s Uterus, Alleges Lawsuit Filed by Parker Waichman LLP
4. Rottenstein Law Group LLP Comments on News Reports of Mirena IUD Side Effects
5. Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations
6. New Jersey Mirena IUD Lawsuit Consolidation Moving Along, Rottenstein Law Group LLP Reports
7. Mirena IUD Lawsuits: Bernstein Liebhard LLP Looks Ahead to Next Case Management Conference in New Jersey Mirena Side Effects Litigation
8. Buckfire & Buckfire, P.C. Lawyers Now Accepting Michigan Mirena IUD Lawsuits
9. New Jersey Court Consolidates Statewide Mirena IUD Lawsuits, Rottenstein Law Group LLP Reports
10. Mirena IUD Lawsuit Update: Supreme Court of New Jersey Centralizes Litigation; Parker Waichman LLP Underscores the Advantages of this Decision
11. Mirena Lawsuit News: Bernstein Liebhard LLP Notes Establishment of Mirena Side Effects Litigation in New Jersey Superior Court, Issuance of First Case Management Order
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... The Providence Fertility Center ... more about their fertility and egg freezing. , Date and Time: October 8, 2015 ... 7PM , This hip and informative event will discuss the basics of female fertility ...
(Date:9/4/2015)... ... 04, 2015 , ... Georgia Insurance Advisors, a locally owned ... to provide for the family of Grace, a young local girl battling restrictive ... leads to diastolic dysfunction – the inability to adequately move blood through the ...
(Date:9/4/2015)... ... September 04, 2015 , ... Inmar announced today ... meeting of its Product, Quality and Manufacturers, Dietary Supplements and Supply Chain Committees. ... in the consumer goods industry, it can be difficult for companies to navigate, ...
(Date:9/4/2015)... ... September 04, 2015 , ... Scalability Experts (SE) announced that ... at this year’s Microsoft Worldwide Partner Conference that was held in Orlando, Florida. ... Winner for Data Platform services, the 2015 HP and Microsoft “Outstanding Frontline Partner” ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... CEREC technology is now available at CitiDent. CEREC is a newer method for ... to saving time for patients by eliminating the need for multiple appointments, CEREC ...
Breaking Medicine News(10 mins):Health News:The Providence Fertility Center to Host Fertility Cocktail Hour on October 8, 2015 at Waterman Grille for Women Who Wish to Learn About Their Fertility and Egg Freezing 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2
... , WASHINGTON, June 8 The Council for American Medical ... development and treatment of life-threatening illnesses in Muslim nations. ... ) , , In his address to the ... "All of us must recognize that education and innovation will ...
... Public Campaign Action Fund analysis finds that nine Republican Senators ... , WASHINGTON, June 8 The nine Republican Senators ... express their opposition to a central part of his health ... industry donations, a new analysis from Public Campaign Action Fund ...
... Phase 2 Diabetes Study Results Presented at ADA Annual Meeting ... VIVUS, Inc. (Nasdaq: VVUS ), a biopharmaceutical company ... diabetes and sexual health, today announced that data from a ... type 2 diabetes are being highlighted in an oral podium ...
... MONDAY, June 8 (HealthDay News) -- Middle-aged adults who don,t ... blood pressure, a new study has found. , Over the ... of Chicago and colleagues collected health information, such as blood ... with an average age of 40. Sleep duration was measured ...
... , - Innovative Program to Increase Access to Care ... MILWAUKEE, June 8 Managed Health Services (MHS) today announced ... Center in Milwaukee, to open MHS Convenient Care Clinic. ... 4061 North 54th Street, the clinic will offer residents of ...
... stimulation to prevent airway closure during sleep , ... a private medical device company, today announced it has ... Earlier in 2009, Inspire announced the first human implant ... Sleep Apnea (OSA). Since this announcement, Inspire continued ...
Cached Medicine News:Health News:Council for American Medical Innovation Applauds President Obama's Pledge to Invest in Science, Technology and Health Abroad 2Health News:VIVUS' Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes 2Health News:VIVUS' Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes 3Health News:VIVUS' Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes 4Health News:VIVUS' Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes 5Health News:VIVUS' Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes 6Health News:VIVUS' Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes 7Health News:Lack of Sleep Can Raise Blood Pressure Over Time 2Health News:Managed Health Services Partners With Milwaukee Health Services to Increase Access to Care for Underserved Communities 2Health News:Managed Health Services Partners With Milwaukee Health Services to Increase Access to Care for Underserved Communities 3Health News:Inspire Medical Systems Completes $17 Million Series B Financing 2Health News:Inspire Medical Systems Completes $17 Million Series B Financing 3
(Date:9/4/2015)... , September 4, 2015 ... announces that Hutchison MediPharma Limited ("HMP"), its drug ... the second proof-of-concept ("POC") trial of fruquintinib in ... ("NSCLC") in China .  The ... in meeting the primary efficacy endpoint of progression ...
(Date:9/3/2015)... , Sept. 3, 2015 ... of New Drugs, Industry Changes and Emerging Opportunities ... human ovaries? Visiongain,s new study forecasts those pharmaceutical ... in that industry. You also explore trends, results, ... Our report gives revenue predictions to 2025 at ...
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 ... – Your New Guide to that Market, its R&D and ... want to assess the future of cancer-treating medicines? Visiongain,s new ... helping you stay ahead. There you discover financial data, R&D ... In our analysis you see forecasted sales ...
Breaking Medicine Technology:Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 2World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 7
... Vary in Their Prescribing Patterns of Levodopa/Carbidopa and Dopamine ... Mass., March 4 Decision Resources, one of the ... and healthcare issues, finds that second-line patient share of ... to 35.2 percent since last year,s report. Most of ...
... in Small, Ambulatory Physician PracticesSCHAUMBURG, Ill., March 3 ... Information Technology (CCHIT(R)), the federally recognized body for ... announced it will develop dermatology-specific functionality criteria beginning ... a response to an application from the American ...
Cached Medicine Technology:Teva's Azilect Use Dramatically Increases in Second-Line Therapy for the Treatment of Parkinson's Disease 2Teva's Azilect Use Dramatically Increases in Second-Line Therapy for the Treatment of Parkinson's Disease 3Certification Commission for Healthcare Information Technology to Develop Dermatology-Specific Functionality Criteria for Electronic Health Record (EHR) Technology 2
... Plate Capability The Equalizer 384 includes ... and equal tip spacing, choice of two software ... addition, this model allows you to evenly space ... accessing many gels and for use with 384 ...
... 384 Well Plate Capability The Equalizer ... original Equalizerexpandable and equal tip spacing, choice of ... capabilities. In addition, this model allows you to ... loading and accessing many gels and for use ...
... System A lower cost alternative to Equalizers, ... multi-sample transfers between two different vessel configurations. With ... spacing can be quickly and easily adjusted for ... plates. Ergonomic Design for Unparalleled Comfort ...
... Exp Expandable Tip System A lower ... allows you to perform multi-sample transfers between two ... of a knob, tip spacing can be quickly ... tubes) or 96 well plates. Ergonomic Design ...
Medicine Products: